NCT03534154View on ClinicalTrials.gov

Developing and Validating Blood and Imaging BIOmarkers of AXonal Injury Following Traumatic Brain Injury

CompletedOBSERVATIONAL
Enrollment

313

Participants

Timeline

Start Date

November 30, 2017

Primary Completion Date

April 30, 2021

Study Completion Date

December 30, 2021

Conditions
Traumatic Brain Injury
Interventions
DIAGNOSTIC_TEST

MRI

Magnetic Resonance Imaging

DIAGNOSTIC_TEST

Blood Sampling

Sampling of serum

DIAGNOSTIC_TEST

Microdialysis

Monitoring of cerebral fluid protein levels

DIAGNOSTIC_TEST

Neuropsychological tests

Battery of tests to assess cognitive function, patient outcomes

DIAGNOSTIC_TEST

MRI (advanced)

Advanced MRI

Trial Locations (5)

Unknown

Fondazione IRCCS, Ca' Granda Ospedale Maggiore Policlinico, Milan

"IRCCS - Istituto di Ricerche Farmacologiche Mario Negri", Milan

University Medical Centre, Ljubljana

Centre Hospitalier Universitaire Vaudois, Lausanne

W12 0NN

Imperial College London, London

All Listed Sponsors
collaborator

Centre Hospitalier Universitaire Vaudois

OTHER

collaborator

University College, London

OTHER

collaborator

Istituto Di Ricerche Farmacologiche Mario Negri

OTHER

collaborator

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

OTHER

lead

Imperial College London

OTHER

NCT03534154 - Developing and Validating Blood and Imaging BIOmarkers of AXonal Injury Following Traumatic Brain Injury | Biotech Hunter | Biotech Hunter